The UK Government has said it will provide £210 million in funding for a project that will track 'superbugs' in Africa and Asia, to curtail the threat posed by antimicrobi
Rare disease specialist Chiesi Pharma has forged an alliance with US biotech Aliada Therapeutics that will apply a technology designed to get drug molecules across the blo
Today saw the debut of a partnership between the UK NHS and an organisation that provides accreditation for clinical research professionals, aiming to attract, develop, an
Gilead Sciences has put $66 million down to start a collaboration with San Diego start-up Tentarix Biotherapeutics to develop new therapeutics for cancer and inflammatory
Neuroscience specialist Harmony Biosciences has agreed to acquire Zynerba, adding its cannabidiol (CBD) gel product Zygel for Fragile X syndrome and other rare neuropsychi
Just days after settling with Thermo Fisher for an undisclosed sum, the family of Henrietta Lacks has filed a lawsuit against Ultragenyx, another US biotech that it accuse
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.